Transforming Global Women’s Health

 Successfully developed and refined the PapEasy Wand (D1), a patented, speculum-free cervical cancer screening device designed to modernize women’s healthcare. 

 Advanced the product by integrating camera technology, swab-based sampling, and tactile guidance to improve usability, accuracy, and overall patient experience. 

 Conducted multi-region research and surveys, gathering valuable insights from women across diverse age groups and geographic locations. 

 Demonstrated strong patient confidence and acceptance for both at-home and assisted screening when supported with clear and accessible instructions. 

 Established research and development operations in collaboration with Providence Care Hospital (Canada), strengthening clinical and innovation efforts. 

 Progressed toward scalable screening models designed for both clinical environments and low-resource settings to expand access globally. 

 Built the foundation for AI-assisted screening workflows to improve efficiency, streamline processes, and support healthcare providers. 

 Expanded the vision for global accessibility, focusing on underserved communities where access to cervical cancer screening is limited.